Form D Explorer

Form C-AR — Rejuve Biotech Inc.

0001669191-25-000296 · filed Apr 30, 2025

Offering

Target
—
Maximum
—
Security type
—
Price per security
—
Deadline
—
Oversubscription
—

Issuer

CIK
1994911
Entity
Corporation
Jurisdiction
CA
Address
215 S Orange St
ORANGE, CA 92866
Phone
—

Most recent fiscal year financials

Total assets
$257,811
Cash
—
Short-term debt
—
Long-term debt
—
Revenues
—
COGS
—
Taxes paid
—
Net income
$-13,513

View the original filing on SEC EDGAR ↗